Abstract: There is disclosed a method and an apparatus for reducing the amount of waste, requiring special handling and possible destruction, in a process involving vaporization, in an evaporator apparatus (1-6, V1-V6), of a water solution containing environmentally hazardous substances. A considerable amount of the water content of said water solution is vaporized in a reusable vaporization chamber (2a). At a certain time, the vaporization process is stopped, so that the remaining water content is 70% to 5% of the initial water content. Thereafter, in a second step, the remaining water solution in the reusable vaporization chamber (2a) is transferred into a separate waste isolating container (6), where the remaining water is subjected to at least one further water-reducing process. The remaining waste, including the environmentally hazardous substances, is left in the waste container for separate handling and possible destruction.

Abstract: There is disclosed a method and an apparatus for reducing the amount of waste, requiring special handling and possible destruction, in a process involving vaporization, in an evaporator apparatus (1-6, V1-V6), of a water solution containing environmentally hazardous substances. A considerable amount of the water content of said water solution is vaporized in a reusable vaporization chamber (2a). At a certain time, the vaporization process is stopped, so that the remaining water content is 70% to 5% of the initial water content. Thereafter, in a second step, the remaining water solution in the reusable vaporization chamber (2a) is transferred into a separate waste isolating container (6), where the remaining water is subjected to at least one further water-reducing process. The remaining waste, including the environmentally hazardous substances, is left in the waste container for separate handling and possible destruction.

Abstract: A pharmaceutical composition for obtaining an improved lung function in a human or an animal lung affected by airway obstruction such as COPD or asthma, is provided. The composition comprises a pharmacologically effective amount of activated carbon comprising adsorbed iodine and/or an adsorbed iodide salt and a sodium/iodide symporter inhibitor, such as perchlorate. Additionally, a method for obtaining an improved lung function in a human or animal lung affected by airway obstruction, such as COPD or asthma, is provided. The method comprises the steps of administering a pharmacologically effective amount of activated carbon comprising adsorbed iodine and/or an adsorbed iodide salt, and administering a sodium/iodide symporter inhibitor, such as perchlorate, in connection to the administration of the pharmacologically effective amount of activated carbon comprising adsorbed iodine and/or an adsorbed iodide salt.

Abstract: The present invention relates to the use of iodinated activated charcoal, optionally in combination with a bromide salt, in treatment of one or more symptom(s) caused by depression, wherein said symptom(s) is/are selected from the group consisting depressive mood, emotional fatigue, mental fatigue which can be chronic, burnout, withdrawal from social situations, anxiety, concentration problems, unpleasant heart palpitations, irregular heart beats, a feeling of pressure in the chest, irritable bowel syndrome and sexual dysfunction.

Abstract: A method of producing bronchorelaxation in the lungs of a human or animal affected by airway obstruction comprises administration of a pharmacologically effective amount to the body or to the intestine of said human or animal of an agent capable of binding mercury in elemental, ionic and/or organic form present in the body or in the intestinal lumen to enhance its excretion via the feces and/or the urine. A corresponding use of the agent and its use for the manufacture of a medicament are also disclosed.

Abstract: A method for producing bronchorelaxation in a human or an animal affected by airway obstruction comprises administration of a pharmacologically effective amount of elemental iodine on activated charcoal (iodinated activated charcoal) to the intestine of said human or animal. A pharmaceutical composition comprising elemental iodine on activated charcoal and uses thereof is also disclosed.